These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12111703

  • 41. Prolonging androgen sensitivity in prostate cancer - a role for COX inhibitors?
    Richards A, McGeechan K, Niknam M, Salomon R, Kurek C, Dong Q, Patel MI.
    ANZ J Surg; 2009 Sep; 79(9):641-7. PubMed ID: 19895521
    [Abstract] [Full Text] [Related]

  • 42. Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment.
    Yang SZ, Eltoum IA, Abdulkadir SA.
    J Cell Biochem; 2006 Apr 15; 97(6):1292-9. PubMed ID: 16552752
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.
    Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET.
    Cancer Res; 2006 Mar 15; 66(6):3087-95. PubMed ID: 16540658
    [Abstract] [Full Text] [Related]

  • 44. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis.
    Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ.
    Cancer Res; 2004 Sep 15; 64(18):6603-9. PubMed ID: 15374974
    [Abstract] [Full Text] [Related]

  • 45. Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer.
    Rubin Grandis J, Zeng Q, Drenning SD.
    Laryngoscope; 2000 May 15; 110(5 Pt 1):868-74. PubMed ID: 10807365
    [Abstract] [Full Text] [Related]

  • 46. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.
    Rocchi P, So A, Kojima S, Signaevsky M, Beraldi E, Fazli L, Hurtado-Coll A, Yamanaka K, Gleave M.
    Cancer Res; 2004 Sep 15; 64(18):6595-602. PubMed ID: 15374973
    [Abstract] [Full Text] [Related]

  • 47. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 15; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.
    Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757
    [Abstract] [Full Text] [Related]

  • 54. Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.
    Cao X, Qin J, Xie Y, Khan O, Dowd F, Scofield M, Lin MF, Tu Y.
    Oncogene; 2006 Jun 22; 25(26):3719-34. PubMed ID: 16449965
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Conditional Akt activation promotes androgen-independent progression of prostate cancer.
    Li B, Sun A, Youn H, Hong Y, Terranova PF, Thrasher JB, Xu P, Spencer D.
    Carcinogenesis; 2007 Mar 22; 28(3):572-83. PubMed ID: 17032658
    [Abstract] [Full Text] [Related]

  • 57. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
    Zhang X, Li W, Olumi AF.
    Clin Cancer Res; 2007 Dec 01; 13(23):7181-90. PubMed ID: 18056199
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.